Neuvivo - Crunchbase Company Profile & Funding

Q: Where is Neuvivo's headquarters?

Neuvivo is located in Palo Alto, California, United States.

Q: Who invested in Neuvivo?

Neuvivo is funded by Primestreet Group.

Q: When was the last funding round for Neuvivo?

Neuvivo closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Neuvivo

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Neuvivo

CB Rank

54635

Neuvivo is a late clinical-stage biopharmaceutical company developing a new ALS treatment.

Founded

obfuscation

Private

Venture - Series Unknown

Palo Alto, California, United States

11-50

www.neuvivo.com/

Biotechnology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Jim Kovach: Chief Medical Affairs Officer
Past Role: CrowdOptic, Senior Vice President Business Development
Ari Azhir: Founder and CEO
Past Role: Neurocea, Founder and CEO

Details

Legal Name

Neuvivo, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Ari Azhir

About the Company

Neuvivo is a private, late-clinical stage biopharmaceutical company committed to creating and delivering advanced treatments for ALS and other neurodegenerative diseases.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

NP001

NP001 is an immune system regulator drug candidate designed to slow or halt ALS progression by targeting diseased macrophages to restore immune balance.

Research & Development

Neuvivo is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Neuvivo	1	obfuscated obfuscation	Primestreet Group	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Primestreet Group	Yes	Venture Round - Neuvivo	Virit Vichitvadakan
Primestreet Group	Yes	Venture Round - Neuvivo	Virit Vichitvadakan
Primestreet Group	Yes	Venture Round - Neuvivo	Virit Vichitvadakan
Primestreet Group	Yes	Venture Round - Neuvivo	Virit Vichitvadakan
Primestreet Group	Yes	Venture Round - Neuvivo	Virit Vichitvadakan